1888PressRelease.com
1888 PressRelease Home Sign In Sign Up Contact Us About Us Sitemap

Braingym.com - Edu-kinesthetics, Inc. Company News Section

Edu-kinesthetics, Inc. Information
Publicist: Diana Ennen
URL: http://www.braingym.com
Paul E. Dennison, Ph.D., is a professional educator, a pioneer in the field of applied neuroscience and a world authority on cognitive skills and reading achievement. With a background in curriculum development and experiential psychology, Dennison conducted research at his learning centers into reading achievement and its relation to brain development. During the last twenty-five years, Dr. Dennison has taught workshops in movement-based learning in more than fifteen countries, being presented with numerous honors, including the Reading Excellence through the Arts (RETA) Award from the International Reading Association.
Edu-kinesthetics, Inc. Press Release -

Braingym.com

08
NOV
Florida Schools Get Moving With New PE Requirement - Discover How Brain Gym Can Supplement These Programs At Upcoming Seminar
With the new requirement for 30 minutes of P.E. in Florida's elementary schools, more students are getting more active and healthier. Another program that many schools are adding is the Brain Gym Program by Dr. Paul Dennison, which is movement-based learning. Dr. Dennison is presenting a seminar in West Palm Beach in February and educators are encouraged to attend.

With Florida's renewed interest in exercise and fitness, thanks to the new requirement for P.E. in elementary schools passed by Florida Legislature af ...
02
APR
ADHD In The Spotlight - Safe And Effective Tools Are Available Including The Brain Gym Program
Brain Gym Programs offer safe and effective tools to help those with ADHD as well as many other health concerns including stress, reading and learning disabilities, etc. Already used in classrooms and workshops throughout the world, Brain Gym offers hope for those looking for alternatives to ADHD medications.

After years of psychiatrists reporting that ADHD stimulants are safe and effective, in February of this year, the Food and Drug Administration (FDA) a ...